Related references
Note: Only part of the references are listed.Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Comparison of clinical usefulness of serum Ca125 and CA19-9 in pancreatic adenocarcinoma diagnosis: meta-analysis and systematic review of literature
Aleksander Skulimowski et al.
BIOMARKERS (2021)
Predictive Values of Preoperative Markers for Resectable Pancreatic Body and Tail Cancer Determined by MDCT to Detect Occult Metastases
He Cheng et al.
WORLD JOURNAL OF SURGERY (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019
Emmanuel Melloul et al.
WORLD JOURNAL OF SURGERY (2020)
Adjuvant Pancreatic Cancer Management: Towards New Perspectives in 2021
Anthony Turpin et al.
CANCERS (2020)
Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
Lei Huang et al.
GUT (2019)
The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer
Zhi-Qiang Wang et al.
CANCER COMMUNICATIONS (2019)
Role of Radical Antegrade Modular Pancreatosplenectomy (RAMPS) and Pancreatic Cancer
Yun Shin Chun
ANNALS OF SURGICAL ONCOLOGY (2018)
Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival
N. Ironside et al.
BRITISH JOURNAL OF SURGERY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The More the Better-Lower Rate of Stage Migration and Better Survival in Patients With Retrieval of 20 or More Regional Lymph Nodes in Pancreatic Cancer A Population-Based Propensity Score Matched and Trend SEER Analysis
Rene Warschkow et al.
PANCREAS (2017)
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Claudio Bassi et al.
SURGERY (2017)
The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system
C. Yang et al.
EJSO (2017)
Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer
Guopei Luo et al.
ANNALS OF SURGERY (2017)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
A Prospective Randomized Controlled Study Comparing Outcomes of Standard Resection and Extended Resection, Including Dissection of the Nerve Plexus and Various Lymph Nodes, in Patients With Pancreatic Head Cancer
Jin-Young Jang et al.
ANNALS OF SURGERY (2014)
Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study
Juan W. Valle et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
Johanna A. M. G. Tol et al.
SURGERY (2014)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Hideki Ueno et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
被撤回的出版物: Meta-analysis of the efficacy of pancreatoduodenectomy with extended lymphadenectomy in the treatment of pancreatic cancer (Retracted article. See vol. 13, pg. 125, 2015)
Xinbao Xu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas Long-term results of a Japanese multicenter randomized controlled trial
Yuji Nimura et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Delayed gastric emptying (DGE) after pancreatic surgery:: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
Moritz N. Wente et al.
SURGERY (2007)
Postpancreatectomy hemorrhage (PPH) -: An International Study Group of Pancreatic Surgery (ISGPS) definition
Moritz N. Wente et al.
SURGERY (2007)
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma
MB Farnell et al.
SURGERY (2005)